MDGL position history
The shares of Madrigal Pharmaceuticals (MDGL) that Paulson & Co. Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q2: 350,200 shares, $81M, 7.9% of portfolio, New
- 2023 Q3: 500,000 shares, $73M, 6.5% of portfolio, Add +42.8%
- 2023 Q4: 1,105,741 shares, $256M, 23.1% of portfolio, Add +121.1%
- 2024 Q1: 1,775,000 shares, $474M, 32.7% of portfolio, Add +60.5%
- 2024 Q2: 1,850,000 shares, $518M, 38.3% of portfolio, Add +4.2%
- 2024 Q3: 2,042,000 shares, $393M, 27.5% of portfolio, Add +10.4%
- 2024 Q4: 2,042,000 shares, $630M, 38.1% of portfolio
- 2025 Q1: 2,099,523 shares, $695M, 39.8% of portfolio, Add +2.8%
- 2025 Q2: 2,089,523 shares, $632M, 31.4% of portfolio, Reduce −0.5%
- 2025 Q3: 1,907,523 shares, $875M, 29.5% of portfolio, Reduce −8.7%
- 2025 Q4: 1,707,522 shares, $994M, 30.5% of portfolio, Reduce −10.5%
- 2026 Q1: 1,392,188 shares, $729M, 23.4% of portfolio, Reduce −18.5%
- 2026 Q2: 1,340,020 shares, $720M, 27.9% of portfolio, Reduce −3.7%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|